First cannabis-based medicine approved by FDA arrives in the U.S. | VailDaily.com | VailDaily.com

First cannabis-based medicine approved by FDA arrives in the U.S.

News | November 3, 2018

Jessica Seaman / The Denver Post
Epidiolex, a medicine made from the marijuana plant but without THC, reduced seizures in children with severe forms of epilepsy and was granted approval for use in the United States

For the first time, a marijuana-based medicine approved by federal regulators is available for prescription in the United States.

The medicine, called Epidiolex, is used to treat seizures related to Lennox-Gastaut and Dravet syndromes, two forms of epilepsy, which is a neurological disorder, according to a news release.

“Because these patients have historically not responded well to available seizure medications, there has been a dire need for new therapies that aim to reduce the frequency and impact of seizures,” said Justin Gover, chief executive officer of GW Pharmaceuticals, the United Kingdom-based company that developed the drug, in a statement.

The oral medication was approved by the U.S. Food and Drug Administration in June. It is made using plant-derived cannabidiol, which lacks the high associated with marijuana.

Epidiolex, when added to other anti-epileptic treatments, reduced the frequency of seizures in patients during clinical trials, according to GW Pharmaceuticals.

Read the full story on The Denver Post website.